Recently Viewed 0
Meet Clearsynth at CPHI Milan · October 6–8, 2026 · Booth 10F24 Book a meeting
My Account Need quick assistance? WhatsApp us +91-22-45045900 sales@clearsynth.com
Home Letermovir API CS-AN-00036

Letermovir

In Stock

Letermovir

API · API Family: Letermovir · CAT No. CS-AN-00036 · CAS No. 917389-32-3
Stock Status: In Stock   Login to view price
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Clearsynth product packaging

Packaging & Handling

Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.

Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.

Letermovir Product Information

Letermovir is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Letermovir. The product is supplied by Clearsynth under CAT No. CS-AN-00036.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Technical Data

Product Name
Letermovir
CAS No.
917389-32-3
CAT No.
CS-AN-00036
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C29H28F4N4O4
Molecular Weight
572.55
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.

Description

Regulatory Description
Letermovir is supplied with detailed characterization data compliant with regulatory guideline. Letermovir can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Letermovir.
Overview
AIC246 is a novel anti-CMV compound which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.
Synonyms
Letermovir
Application Notes
AIC246 is a novel anti-CMV compound which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.
References

Product Applications & Regulatory Search Terms

Useful product, supplier and regulatory search terms for this reference standard.

Buy 917389-32-3Purchase 917389-32-3Order 917389-32-3Enquire 917389-32-3Price of 917389-32-3917389-32-3 Supplier917389-32-3 Manufacturer917389-32-3 ExporterBuy high quality LetermovirPurchase LetermovirLetermovir SuppliersLetermovir ManufacturersLetermovir PriceOrder LetermovirEnquire LetermovirLetermovir CostLetermovir SupplierLetermovir DistributorLetermovir for Method ValidationLetermovir for ANDA FilingLetermovir for Forced Degradation StudiesLetermovir Identification StandardsLetermovir for DMF FilingLetermovir Reference Standard
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.